Sensona's technology delivers portable, 8-minute diagnostic tests using a novel approach based on the exclusive, internal heating system activated by Infra-Red-light sensitive nanoparticles. The unique nanoparticles were invented, synthesized, and purified by Sensona's R&D team. Our technology was recently granted the U.S. patent and several international patents, which provide us exclusive rights to manufacture and use the nanoparticles for the PCR, RT-PCR, qPCR, and other Nucleic Acid Amplification methods. Our portable,  ultrafast, compact, and highly affordable system is the ultimate solution for detecting and rapidly diagnosing contagious outbreaks and provides a powerful tool to slow down the antibiotic-resistance threat. The future is here, and our first challenge is to give a serious fight against SARS-CoV-2. 

COVID-19 portable, rapid diagnostic tests at schools, airports, ambulances, army bases, shopping centers, and many other possibilities are not a dream anymore. The future is here! It's not magic; it's science!

Sensona, Inc.

Sensona, Inc.'s headquarters in Chicago, IL, United States

Description

People (2)

Zoya Cheglakov

Michael Buhle

Jobs